Sophoraflavanone L

Sophoraflavanone L

SCHEMBL30766211

CC(C)=CCOc1cc(O)c2c(c1CC=C(C)C)OC(c1ccc(O)cc1O)CC2=O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.71
CYP19A1 P11511 2/20 0.64
MAOA P21397 2/20 0.61
MAOB P27338 1/20 0.61
ESR1 P03372 4/20 0.59
ABCG2 Q9UNQ0 4/20 0.59
ESR2 Q92731 2/20 0.59
CACNA1G O43497 2/20 0.59
CACNA1H O95180 2/20 0.59
AKR1B10 O60218 2/20 0.59
AKR1B1 P15121 2/20 0.59
PDE5A O76074 1/20 0.59
BACE1 P56817 5/20 0.59
SLC5A1 P13866 2/20 0.59
SLC5A2 P31639 2/20 0.59
PDPK1 O15530 1/20 0.58
PRKCA P17252 1/20 0.58
PRKCQ Q04759 1/20 0.58
ACHE P22303 2/20 0.58
PTGS1 P23219 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29454740 0.91 IDO1 (0.75) IDO1CYP19A1MAOAMAOBESR1
Leachianone G SCHEMBL31237622 0.87 IDO1 (0.81) IDO1CYP19A1MAOAMAOBESR1
Leachianone G SCHEMBL6544629 0.87 IDO1 (0.81) IDO1CYP19A1MAOAMAOBESR1
Leachianone G SCHEMBL6544631 0.87 IDO1 (0.81) IDO1CYP19A1MAOAMAOBESR1
SCHEMBL564110 0.83 IDO1 (1.00) IDO1CYP19A1MAOAMAOBESR1
SCHEMBL17626616 0.83 IDO1 (1.00) IDO1CYP19A1MAOAMAOBESR1
Munduleaflavanone B SCHEMBL14049994 0.81 ESR1 (0.87) IDO1CYP19A1MAOAESR1ABCG2
SCHEMBL29808777 0.79 ABCG2 (0.79) IDO1CYP19A1MAOAMAOBESR1
SCHEMBL17626647 0.79 ABCG2 (0.79) IDO1CYP19A1MAOAMAOBESR1
SCHEMBL27013448 0.79 ABCG2 (0.79) IDO1CYP19A1MAOAMAOBESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016777-A1 COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS BETH ISRAEL DEACONESS MEDICAL CENTER, INC. 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016777-A1 COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS THPO, SERPINB1, SERPINC1 IDO1 3111/4885CYP19A1 1668/4885MAOA 1996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.